{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T18:42:10Z","timestamp":1793472130831,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":1964,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.seizure.2007.11.013","type":"journal-article","created":{"date-parts":[[2008,1,7]],"date-time":"2008-01-07T10:53:42Z","timestamp":1199703222000},"page":"145-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Which contraception for women with epilepsy?"],"prefix":"10.1016","volume":"17","author":[{"given":"Anneliese M.","family":"Schwenkhagen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan R.G.","family":"Stodieck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.seizure.2007.11.013_bib1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2125.2005.02539.x","article-title":"The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects","volume":"61","author":"Sidhu","year":"2006","journal-title":"Br J Clin Pharmacol"},{"issue":"1\u20132","key":"10.1016\/j.seizure.2007.11.013_bib2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0920-1211(01)00305-9","article-title":"Lamotrigine plasma levels reduced by oral contraceptives","volume":"47","author":"Sabers","year":"2001","journal-title":"Epilepsy Res"},{"issue":"4","key":"10.1016\/j.seizure.2007.11.013_bib3","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1212\/01.WNL.0000076485.09353.7A","article-title":"Oral contraceptives reduce lamotrigine plasma levels","volume":"61","author":"Sabers","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2007.11.013_bib4","first-page":"187","article-title":"Lamotrigine plasma levels and combined monophasic oral contraceptives (COC) or a contraceptive vaginla ring. A prospective study in 30 women","volume":"45","author":"Stodieck","year":"2004","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.seizure.2007.11.013_bib5","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1528-1167.2007.00997.x","article-title":"Oral contraceptives induce lamotrigine metabolism: evidence from a double-blind, placebo-controlled trial","volume":"48","author":"Christensen","year":"2007","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.seizure.2007.11.013_bib6","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/j.1528-1167.2005.00605.x","article-title":"Serum valproate levels with oral contraceptive use","volume":"46","author":"Herzog","year":"2005","journal-title":"Epilepsia"},{"issue":"9","key":"10.1016\/j.seizure.2007.11.013_bib7","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/j.1528-1167.2006.00629.x","article-title":"Increased apparent oral clearance of valproic acid during intake of combined contraceptive steroids in women with epilepsy","volume":"47","author":"Galimberti","year":"2006","journal-title":"Epilepsia"},{"issue":"Suppl. 1","key":"10.1016\/j.seizure.2007.11.013_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/13697130500148875","article-title":"Pharmacology of estrogens and progestogens: influence of different routes of administration","volume":"8","author":"Kuhl","year":"2005","journal-title":"Climacteric"},{"key":"10.1016\/j.seizure.2007.11.013_bib9","series-title":"Beeinflussung reproduktiver Funktionen durch synthetische Hormone. I. Kontrazeption mit Hormonen: ein Leitfaden f\u00fcr die Praxis","author":"Taubert","year":"1995"},{"issue":"2","key":"10.1016\/j.seizure.2007.11.013_bib10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0010-7824(96)00137-0","article-title":"Shorter pill-free interval in combined oral contraceptives decreases follicular development","volume":"54","author":"Spona","year":"1996","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.seizure.2007.11.013_bib11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00404-005-0064-4","article-title":"Failure of Implanon contraception in a patient taking carbamazepin for epilepsia","volume":"273","author":"Schindlbeck","year":"2006","journal-title":"Arch Gynecol Obstet"},{"issue":"6","key":"10.1016\/j.seizure.2007.11.013_bib12","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/j.1875-9114.1998.tb03161.x","article-title":"Enhanced metabolism of levonorgestrel during phenobarbital treatment and resultant pregnancy","volume":"18","author":"Shane-McWhorter","year":"1998","journal-title":"Pharmacotherapy"},{"issue":"6","key":"10.1016\/j.seizure.2007.11.013_bib13","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0010-7824(86)90044-2","article-title":"Contraception by Norplant subdermal capsules is not reliable in epileptic patients on anticonvulsant treatment","volume":"33","author":"Haukkamaa","year":"1986","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.seizure.2007.11.013_bib14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0010-7824(86)90018-1","article-title":"Enhanced metabolism of levonorgestrel during phenytoin treatment in a woman with Norplant implants","volume":"33","author":"Odlind","year":"1986","journal-title":"Contraception"},{"issue":"5 Pt 1","key":"10.1016\/j.seizure.2007.11.013_bib15","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/01.AOG.0000117082.49490.d5","article-title":"Effects of hormonal contraception on bone mineral density after 24 months of use","volume":"103","author":"Berenson","year":"2004","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.seizure.2007.11.013_bib16","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jadohealth.2004.07.005","article-title":"Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls","volume":"35","author":"Cromer","year":"2004","journal-title":"J Adolesc Health"},{"issue":"2","key":"10.1016\/j.seizure.2007.11.013_bib17","first-page":"233","article-title":"Bone mineral density in women using depot medroxyprogesterone acetate for contraception","volume":"93","author":"Scholes","year":"1999","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.seizure.2007.11.013_bib18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0010-7824(98)00125-5","article-title":"Bone density among long-term users of medroxyprogesterone acetate as a contraceptive","volume":"58","author":"Paiva","year":"1998","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.seizure.2007.11.013_bib19","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/humrep\/deh058","article-title":"Is previous use of hormonal contraception associated with a detrimental effect on subsequent fecundity?","volume":"19","author":"Hassan","year":"2004","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.seizure.2007.11.013_bib20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00006250-199102000-00019","article-title":"Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years\u2019 comparative experience of levonorgestrel- and copper-releasing intrauterine devices","volume":"77","author":"Toivonen","year":"1991","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.seizure.2007.11.013_bib21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1783\/147118902101195992","article-title":"Observational series on women using the contraceptive Mirena concurrently with anti-epileptic and other enzyme-inducing drugs","volume":"28","author":"Bounds","year":"2002","journal-title":"J Fam Plann Reprod Health Care"},{"issue":"8","key":"10.1016\/j.seizure.2007.11.013_bib22","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1056\/NEJMoa010438","article-title":"Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women","volume":"345","author":"Hubacher","year":"2001","journal-title":"N Engl J Med"},{"issue":"9234","key":"10.1016\/j.seizure.2007.11.013_bib23","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0140-6736(00)02699-4","article-title":"Intrauterine device and upper-genital-tract infection","volume":"356","author":"Grimes","year":"2000","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.seizure.2007.11.013_bib24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.contraception.2006.09.010","article-title":"Use of IUD and subsequent fertility-follow-up after participation in a randomized clinical trial","volume":"75","author":"Hov","year":"2007","journal-title":"Contraception"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131107002324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131107002324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:36:47Z","timestamp":1761010607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131107002324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S1059131107002324"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2007.11.013","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Which contraception for women with epilepsy?","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2007.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}